Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Shareholder vote results
  5. 4 Option exercise See Remarks acquired 19,357 shares (option exercise)
  6. 8-K Event Regulation FD disclosure · Other events
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13D/A Stake Beneficial Ownership Report
  9. 4 Option exercise President and CEO acquired 559,073 shares (option exercise)
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations · Regulation FD disclosure · Other events
  13. SCHEDULE 13D/A Stake Beneficial Ownership Report
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 4 of 30 · 584 filings